784 related articles for article (PubMed ID: 25129854)
1. Exosomal miR-1290 and miR-375 as prognostic markers in castration-resistant prostate cancer.
Huang X; Yuan T; Liang M; Du M; Xia S; Dittmar R; Wang D; See W; Costello BA; Quevedo F; Tan W; Nandy D; Bevan GH; Longenbach S; Sun Z; Lu Y; Wang T; Thibodeau SN; Boardman L; Kohli M; Wang L
Eur Urol; 2015 Jan; 67(1):33-41. PubMed ID: 25129854
[TBL] [Abstract][Full Text] [Related]
2. Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer.
Liu Q; Yu Z; Yuan S; Xie W; Li C; Hu Z; Xiang Y; Wu N; Wu L; Bai L; Li Y
Oncotarget; 2017 Feb; 8(8):13048-13058. PubMed ID: 28055956
[TBL] [Abstract][Full Text] [Related]
3. Exosomal miR-1246 and miR-155 as predictive and prognostic biomarkers for trastuzumab-based therapy resistance in HER2-positive breast cancer.
Zhang Z; Zhang L; Yu G; Sun Z; Wang T; Tian X; Duan X; Zhang C
Cancer Chemother Pharmacol; 2020 Dec; 86(6):761-772. PubMed ID: 33068176
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of exosome-encapsulated microRNA-451a as a minimally invasive biomarker for prediction of recurrence and prognosis in pancreatic ductal adenocarcinoma.
Takahasi K; Iinuma H; Wada K; Minezaki S; Kawamura S; Kainuma M; Ikeda Y; Shibuya M; Miura F; Sano K
J Hepatobiliary Pancreat Sci; 2018 Feb; 25(2):155-161. PubMed ID: 29130611
[TBL] [Abstract][Full Text] [Related]
5. Phase 2 study of circulating microRNA biomarkers in castration-resistant prostate cancer.
Lin HM; Mahon KL; Spielman C; Gurney H; Mallesara G; Stockler MR; Bastick P; Briscoe K; Marx G; Swarbrick A; Horvath LG
Br J Cancer; 2017 Apr; 116(8):1002-1011. PubMed ID: 28278515
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Value of Novel Liquid Biomarkers in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Enzalutamide: A Prospective Observational Study.
Benoist GE; van Oort IM; Boerrigter E; Verhaegh GW; van Hooij O; Groen L; Smit F; de Mol P; Hamberg P; Dezentjé VO; Mehra N; Gerritsen W; Somford DM; van Erp NPH; Schalken JA
Clin Chem; 2020 Jun; 66(6):842-851. PubMed ID: 32408351
[TBL] [Abstract][Full Text] [Related]
7. The Identification of Plasma Exosomal miR-423-3p as a Potential Predictive Biomarker for Prostate Cancer Castration-Resistance Development by Plasma Exosomal miRNA Sequencing.
Guo T; Wang Y; Jia J; Mao X; Stankiewicz E; Scandura G; Burke E; Xu L; Marzec J; Davies CR; Lu JJ; Rajan P; Grey A; Tipples K; Hines J; Kudahetti S; Oliver T; Powles T; Alifrangis C; Kohli M; Shaw G; Wang W; Feng N; Shamash J; Berney D; Wang L; Lu YJ
Front Cell Dev Biol; 2020; 8():602493. PubMed ID: 33490068
[TBL] [Abstract][Full Text] [Related]
8. Expression differences of circulating microRNAs in metastatic castration resistant prostate cancer and low-risk, localized prostate cancer.
Nguyen HC; Xie W; Yang M; Hsieh CL; Drouin S; Lee GS; Kantoff PW
Prostate; 2013 Mar; 73(4):346-54. PubMed ID: 22887127
[TBL] [Abstract][Full Text] [Related]
9. Exosomal miRNA profiling before and after surgery revealed potential diagnostic and prognostic markers for lung adenocarcinoma.
Xue X; Wang C; Xue Z; Wen J; Han J; Ma X; Zang X; Deng H; Guo R; Asuquo IP; Qin C; Wang H; Gao Q; Liu S; Wang J
Acta Biochim Biophys Sin (Shanghai); 2020 Mar; 52(3):281-293. PubMed ID: 32073597
[TBL] [Abstract][Full Text] [Related]
10. Influence of peripheral whole-blood microRNA-7 and microRNA-221 high expression levels on the acquisition of castration-resistant prostate cancer: evidences from in vitro and in vivo studies.
Santos JI; Teixeira AL; Dias F; Maurício J; Lobo F; Morais A; Medeiros R
Tumour Biol; 2014 Jul; 35(7):7105-13. PubMed ID: 24760272
[TBL] [Abstract][Full Text] [Related]
11. MicroRNAs in Serum Exosomes as Potential Biomarkers in Clear-cell Renal Cell Carcinoma.
Zhang W; Ni M; Su Y; Wang H; Zhu S; Zhao A; Li G
Eur Urol Focus; 2018 Apr; 4(3):412-419. PubMed ID: 28753793
[TBL] [Abstract][Full Text] [Related]
12. Circulating microRNAs are associated with docetaxel chemotherapy outcome in castration-resistant prostate cancer.
Lin HM; Castillo L; Mahon KL; Chiam K; Lee BY; Nguyen Q; Boyer MJ; Stockler MR; Pavlakis N; Marx G; Mallesara G; Gurney H; Clark SJ; Swarbrick A; Daly RJ; Horvath LG
Br J Cancer; 2014 May; 110(10):2462-71. PubMed ID: 24714754
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of miR-129 in peripheral blood mononuclear cells is a diagnostic and prognostic biomarker in prostate cancer.
Xu S; Yi XM; Zhou WQ; Cheng W; Ge JP; Zhang ZY
Int J Clin Exp Pathol; 2015; 8(11):14335-44. PubMed ID: 26823749
[TBL] [Abstract][Full Text] [Related]
14. Urinary exosomal microRNA profiling in intermediate-risk prostate cancer.
Kim MY; Shin H; Moon HW; Park YH; Park J; Lee JY
Sci Rep; 2021 Apr; 11(1):7355. PubMed ID: 33795765
[TBL] [Abstract][Full Text] [Related]
15. Plasma miRNAs in diagnosis and prognosis of pancreatic cancer: A miRNA expression analysis.
Zhou X; Lu Z; Wang T; Huang Z; Zhu W; Miao Y
Gene; 2018 Oct; 673():181-193. PubMed ID: 29913239
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA expression signature of castration-resistant prostate cancer: the microRNA-221/222 cluster functions as a tumour suppressor and disease progression marker.
Goto Y; Kojima S; Nishikawa R; Kurozumi A; Kato M; Enokida H; Matsushita R; Yamazaki K; Ishida Y; Nakagawa M; Naya Y; Ichikawa T; Seki N
Br J Cancer; 2015 Sep; 113(7):1055-65. PubMed ID: 26325107
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic and prognostic relevance of circulating exosomal miR-373, miR-200a, miR-200b and miR-200c in patients with epithelial ovarian cancer.
Meng X; Müller V; Milde-Langosch K; Trillsch F; Pantel K; Schwarzenbach H
Oncotarget; 2016 Mar; 7(13):16923-35. PubMed ID: 26943577
[TBL] [Abstract][Full Text] [Related]
18. Validation of the four-miRNA biomarker panel MiCaP for prediction of long-term prostate cancer outcome.
Strand SH; Schmidt L; Weiss S; Borre M; Kristensen H; Rasmussen AKI; Daugaard TF; Kristensen G; Stroomberg HV; Røder MA; Brasso K; Mouritzen P; Sørensen KD
Sci Rep; 2020 Jul; 10(1):10704. PubMed ID: 32612164
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of serum exosomal microRNAs as diagnostic and prognostic biomarkers for hepatocellular carcinoma.
Xue X; Zhao Y; Wang X; Qin L; Hu R
J Cell Biochem; 2019 Jan; 120(1):135-142. PubMed ID: 30238497
[TBL] [Abstract][Full Text] [Related]
20. Decreased levels of serum exosomal miR-638 predict poor prognosis in hepatocellular carcinoma.
Shi M; Jiang Y; Yang L; Yan S; Wang YG; Lu XJ
J Cell Biochem; 2018 Jun; 119(6):4711-4716. PubMed ID: 29278659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
